Tyzeka - telbivudine
Navigation: NDC > Supplier starting with: N > NOVARTIS PHARMACEUTICALS CORPORATION| Field | Value |
|---|---|
| NDC Code: | 0078-0539 |
| Proprietary Name: | Tyzeka |
| Suffix: | |
| Non-Proprietary Name: | telbivudine |
| Dosage Form: | SOLUTION |
| Method: | ORAL |
| Original Marketing Date: | 28-04-2009 |
| Category Name: | NDA |
| Application Number: | NDA022154 |
| Labeler: | NOVARTIS PHARMACEUTICALS CORPORATION |
| Substance Name: | TELBIVUDINE |
| Active Numerator Strength: | 20 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| DEA Schedule: |